Original Research

The amplification of 1q21 is an adverse prognostic factor in patients with multiple myeloma in a Chinese population

Yu W, Guo R, Qu X, Qiu H, Li J, Zhang R, Chen L

OncoTargets and Therapy 2016, 9:295-302

Published Date: 12 January 2016